These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22532824)

  • 1. Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.
    Latka MH; Fielding K; Gray GE; Bekker LG; Nchabeleng M; Mlisana K; Nielson T; Roux S; Mkhize B; Mathebula M; Naicker N; de Bruyn G; Kublin J; Churchyard GJ;
    PLoS One; 2012; 7(4):e31387. PubMed ID: 22532824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
    Moodie Z; Metch B; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; Bentley C; Gilbert PB; Robertson M; Kublin J; Corey L; Gray GE
    PLoS One; 2015; 10(9):e0137666. PubMed ID: 26368824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
    Gray GE; Moodie Z; Metch B; Gilbert PB; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; McElrath MJ; Robertson M; Kublin J; Corey L;
    Lancet Infect Dis; 2014 May; 14(5):388-96. PubMed ID: 24560541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
    Gray GE; Allen M; Moodie Z; Churchyard G; Bekker LG; Nchabeleng M; Mlisana K; Metch B; de Bruyn G; Latka MH; Roux S; Mathebula M; Naicker N; Ducar C; Carter DK; Puren A; Eaton N; McElrath MJ; Robertson M; Corey L; Kublin JG;
    Lancet Infect Dis; 2011 Jul; 11(7):507-15. PubMed ID: 21570355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa.
    Moodley J; Naidoo S; Wand H; Ramjee G;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):5-11. PubMed ID: 26259895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.
    Otwombe KN; Sikkema KJ; Dietrich J; de Bruyn G; van der Watt M; Gray GE
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):211-8. PubMed ID: 21765362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Bekker LG; Moodie Z; Grunenberg N; Laher F; Tomaras GD; Cohen KW; Allen M; Malahleha M; Mngadi K; Daniels B; Innes C; Bentley C; Frahm N; Morris DE; Morris L; Mkhize NN; Montefiori DC; Sarzotti-Kelsoe M; Grant S; Yu C; Mehra VL; Pensiero MN; Phogat S; DiazGranados CA; Barnett SW; Kanesa-Thasan N; Koutsoukos M; Michael NL; Robb ML; Kublin JG; Gilbert PB; Corey L; Gray GE; McElrath MJ;
    Lancet HIV; 2018 Jul; 5(7):e366-e378. PubMed ID: 29898870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    Laher F; Moodie Z; Cohen KW; Grunenberg N; Bekker LG; Allen M; Frahm N; Yates NL; Morris L; Malahleha M; Mngadi K; Daniels B; Innes C; Saunders K; Grant S; Yu C; Gilbert PB; Phogat S; DiazGranados CA; Koutsoukos M; Van Der Meeren O; Bentley C; Mkhize NN; Pensiero MN; Mehra VL; Kublin JG; Corey L; Montefiori DC; Gray GE; McElrath MJ; Tomaras GD
    PLoS Med; 2020 Feb; 17(2):e1003038. PubMed ID: 32092060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.
    Caplan MR; Landovitz RJ; Palanee-Phillips T; Nair G; Mhlanga F; Balkus JE; Riddler SA; Gorbach PM
    AIDS Care; 2019 Jun; 31(6):746-753. PubMed ID: 30759997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
    Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
    Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent condom use among highly effective contraceptive users in an HIV-endemic area in rural Kenya.
    Kosugi H; Shibanuma A; Kiriya J; Wafula SW; Jimba M
    PLoS One; 2019; 14(5):e0216208. PubMed ID: 31059524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy incidence and correlates in a clinical trial preparedness study, North West Province South Africa.
    Chetty-Makkan CM; Fielding K; Feldblum PJ; Price MA; Kruger P; Makkan H; Charalambous S; Latka MH
    PLoS One; 2014; 9(5):e95708. PubMed ID: 24802651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.
    Hanass-Hancock J; Carpenter B; Reddy T; Nzuza A; Gaffoor Z; Goga A; Andrasik M
    Trials; 2021 Dec; 22(1):897. PubMed ID: 34895272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High HIV incidence among young women in South Africa: Data from a large prospective study.
    Palanee-Phillips T; Rees HV; Heller KB; Ahmed K; Batting J; Beesham I; Heffron R; Justman J; Makkan H; Mastro TD; Morrison SA; Mugo N; Nair G; Kiarie J; Philip NM; Pleaner M; Reddy K; Selepe P; Steyn PS; Scoville CW; Smit J; Thomas KK; Donnell D; Baeten JM;
    PLoS One; 2022; 17(6):e0269317. PubMed ID: 35657948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
    Malahleha M; Laher F; Dilraj A; Smith P; Gray GE; Grove D; Odhiambo JA; Andrasik MP; Grunenberg NA; Moodie Z; Huang Y; Borate BR; Gillespie KM; Allen M; Atujuna M; Singh N; Kalonji D; Meintjes G; Kotze P; Bekker LG; Janes H
    AIDS Behav; 2023 Sep; 27(9):3027-3037. PubMed ID: 36929319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000.
    Desgrées-Du-Loû A; Msellati P; Viho I; Yao A; Yapi D; Kassi P; Welffens-Ekra C; Mandelbrot L; Dabis F;
    Int J STD AIDS; 2002 Jul; 13(7):462-8. PubMed ID: 12171665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
    Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.
    Taha TE; Dallabetta GA; Hoover DR; Chiphangwi JD; Mtimavalye LA; Liomba GN; Kumwenda NI; Miotti PG
    AIDS; 1998 Jan; 12(2):197-203. PubMed ID: 9468369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.